As Archer (ADM) Stock Price Declined, Shareholder Campbell & Company Investment Adviser Has Trimmed by $668,306 Its Stake; Chemocentryx (CCXI) Share Value Declined While Carmignac Gestion Has Raised Holding

Archer-Daniels-Midland Company (NYSE:ADM) Logo

Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 60.54% based on its latest 2019Q1 regulatory filing with the SEC. Carmignac Gestion bought 741,210 shares as the company’s stock declined 38.33% . The institutional investor held 1.97M shares of the health care company at the end of 2019Q1, valued at $27.30 million, up from 1.22M at the end of the previous reported quarter. Carmignac Gestion who had been investing in Chemocentryx Inc for a number of months, seems to be bullish on the $399.01 million market cap company. The stock decreased 2.42% or $0.17 during the last trading session, reaching $6.85. About 429,900 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has declined 28.17% since August 14, 2018 and is downtrending. It has underperformed by 28.17% the S&P500. Some Historical CCXI News: 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx

Campbell & Company Investment Adviser Llc decreased its stake in Archer (ADM) by 76.21% based on its latest 2019Q1 regulatory filing with the SEC. Campbell & Company Investment Adviser Llc sold 15,542 shares as the company’s stock declined 6.78% . The hedge fund held 4,852 shares of the packaged foods company at the end of 2019Q1, valued at $209,000, down from 20,394 at the end of the previous reported quarter. Campbell & Company Investment Adviser Llc who had been investing in Archer for a number of months, seems to be less bullish one the $20.50 billion market cap company. The stock decreased 2.52% or $0.95 during the last trading session, reaching $36.81. About 2.20M shares traded. Archer-Daniels-Midland Company (NYSE:ADM) has declined 13.24% since August 14, 2018 and is downtrending. It has underperformed by 13.24% the S&P500. Some Historical ADM News: 23/05/2018 – Brazil withholds corn subsidies owed to farmers, grain handlers; 17/05/2018 – ALICORP REPORTS ASSIGNMENT OF BUY PACT FOR ADM-SAO S.A; 19/03/2018 – ADM Realigns Business Segments to Further Accelerate Growth; 19/03/2018 – SCHRODER DECLINED TO COMMENT ON ADM MERGER TALKS; 11/04/2018 – ClinicalTrial US: Evaluation of ADM Soft Tissue Reinforcement; 01/05/2018 – Archer Daniels Midland: Even More Confident About 2018; 25/05/2018 – ADM SAYS STRIKE ALSO AFFECTING ABILITY TO SHIP SOY, PRODUCTS; 25/05/2018 – ADM: TRUCK STRIKE AFFECTING MATERIALS ARRIVING AT BRAZIL PLANTS; 27/04/2018 – BULGARIAN AGRICULTURE MINISTRY COMMENTS ON ADM ON WEBSITE; 16/05/2018 – ADM MAY LOOK AT EXPANDING CORN PROCESSING OPERATIONS IN SOUTH AMERICA -CFO

Since April 29, 2019, it had 4 buys, and 0 insider sales for $1.58 million activity. On Tuesday, August 6 LUCIANO JUAN R bought $199,990 worth of Archer-Daniels-Midland Company (NYSE:ADM) or 5,457 shares.

Investors sentiment decreased to 1.08 in Q1 2019. Its down 0.10, from 1.18 in 2018Q4. It dived, as 62 investors sold ADM shares while 195 reduced holdings. 75 funds opened positions while 202 raised stakes. 415.31 million shares or 4.43% less from 434.55 million shares in 2018Q4 were reported. Horrell Cap Management Inc has invested 0.03% of its portfolio in Archer-Daniels-Midland Company (NYSE:ADM). Alliancebernstein Limited Partnership holds 1.42M shares. Brookfield Asset Management Inc accumulated 85,066 shares. Gradient Investments Limited Liability has 26 shares. Madison Inv Hldgs has 0.12% invested in Archer-Daniels-Midland Company (NYSE:ADM). Riverhead Capital Ltd stated it has 0.07% in Archer-Daniels-Midland Company (NYSE:ADM). 325 are owned by Massmutual Trust Fsb Adv. Amundi Pioneer Asset Mngmt Incorporated has 1.39 million shares. Markel Corp reported 1.46M shares. Weiss Asset Mgmt Limited Partnership has 4,872 shares for 0.02% of their portfolio. State Of Alaska Department Of Revenue reported 116,296 shares or 0.09% of all its holdings. 104,326 were reported by Cubist Systematic Strategies Ltd Liability Corporation. Lowe Brockenbrough holds 18,412 shares or 0.11% of its portfolio. Stephens Ar invested in 0.08% or 80,038 shares. Moody National Bank & Trust Tru Division, Texas-based fund reported 100 shares.

Campbell & Company Investment Adviser Llc, which manages about $1.13 billion and $203.38 million US Long portfolio, upped its stake in Alliant Energy Corp (NYSE:LNT) by 13,880 shares to 21,422 shares, valued at $1.01 million in 2019Q1, according to the filing. It also increased its holding in Geopark Ltd by 22,519 shares in the quarter, for a total of 36,861 shares, and has risen its stake in Polyone Corp (NYSE:POL).

More notable recent Archer-Daniels-Midland Company (NYSE:ADM) news were published by: Seekingalpha.com which released: “Archer Daniels Midland -2% after soggy profits – Seeking Alpha” on April 26, 2019, also Seekingalpha.com with their article: “Archer Daniels Midland declares $0.35 dividend – Seeking Alpha” published on February 05, 2019, Seekingalpha.com published: “Archer Daniels Midland extends buyback program – Seeking Alpha” on August 08, 2019. More interesting news about Archer-Daniels-Midland Company (NYSE:ADM) were released by: Seekingalpha.com and their article: “ADM powers 6% as BMO upgrades, CEO Luciano buys $1M in shares – Seeking Alpha” published on April 29, 2019 as well as Seekingalpha.com‘s news article titled: “EPA grants 31 small refinery waivers; RIN values plunge – Seeking Alpha” with publication date: August 12, 2019.

Investors sentiment increased to 1.44 in Q1 2019. Its up 0.51, from 0.93 in 2018Q4. It improved, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. Element Cap Management Limited Liability Corporation invested in 0.01% or 11,906 shares. Citadel Advsrs Limited Liability holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 26,133 shares. Alliancebernstein Limited Partnership reported 46,500 shares. Swiss Bancorp holds 41,500 shares. Sg Americas Ltd Liability, a New York-based fund reported 20,240 shares. Panagora Asset Incorporated accumulated 308,857 shares or 0.02% of the stock. Consonance Capital Mngmt LP holds 1.67M shares. Strs Ohio stated it has 55,800 shares. Daiwa Gru invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Grp One Trading LP reported 9,979 shares. Morgan Stanley has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Jpmorgan Chase & Co has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). 23,876 are owned by Art Advisors Lc. Deutsche Fincl Bank Ag has invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Dekabank Deutsche Girozentrale has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI).

Carmignac Gestion, which manages about $8.58 billion US Long portfolio, decreased its stake in Agnico Eagle Mines Ltd (NYSE:AEM) by 265,055 shares to 2.53 million shares, valued at $110.24M in 2019Q1, according to the filing. It also reduced its holding in Vipshop Holdings Ltd (NYSE:VIPS) by 1.13M shares in the quarter, leaving it with 4.53M shares, and cut its stake in Banco Macro Sa (NYSE:BMA).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Reports First Quarter 2019 Financial Results and Recent Highlights – GlobeNewswire” on May 06, 2019, also Seekingalpha.com with their article: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q2 2019 Results – Earnings Call Transcript – Seeking Alpha” published on August 06, 2019, Benzinga.com published: “85 Biggest Movers From Yesterday – Benzinga” on August 07, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx, Inc. 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” published on August 06, 2019 as well as Benzinga.com‘s news article titled: “The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout – Benzinga” with publication date: August 07, 2019.

Archer-Daniels-Midland Company (NYSE:ADM) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *